TFF PHARMAC.INC.  DL-,001
TFF PHARMAC.INC. DL-,001
Share · US87241J2033 · TFFP · A3E2FW (XNCM)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 7,69 % 3,16 % -77,61 % -96,45 % -99,95 %

Company Profile for TFF PHARMAC.INC. DL-,001 Share

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.

Company Data

Name TFF PHARMAC.INC. DL-,001
Company TFF Pharmaceuticals, Inc.
Symbol TFFP
Website https://www.tffpharma.com
Primary Exchange XNCM Frankfurt
WKN A3E2FW
ISIN US87241J2033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Harlan F. Weisman
Country United States of America
Currency EUR
Employees 0,0 T
Address 1751 River Run, 76107 Austin
IPO Date 2019-10-25

Ticker Symbols

Name Symbol
NASDAQ TFFP

More Shares

Investors who TFF PHARMAC.INC. DL-,001 hold also have the following shares in their portfolio:
SIBUR SEC. 20/25 REGS
SIBUR SEC. 20/25 REGS Bond
USD/DOP DOMINIKANISCHER PESO
USD/DOP DOMINIKANISCHER PESO Currency
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025